ÐÏࡱá > þÿ À  þÿÿÿ ¾ ¿ ÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿì¥Á g ð¿ U1 bjbj.ÿ.ÿ 94 L•jL•j:÷ ÿÿ ÿÿ ÿÿ · ê ê } } } } } ÿÿÿÿ ‘ ‘ ‘ ‘ \ í t ‘ ¹ ð a a a a a < < < $ ©" ¶ _% n : 9 } < < < < < : } } a a Û s h h h < N } a } a h < h h h a ÿÿÿÿ @ÜaÒtÜ ÿÿÿÿ Š ¾ h ‰ 0 ¹ h Í% H Í% h Í% } h ˜ < < h < < < < < : : X < < < ¹ < < < < ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ ÿÿÿÿ Í% < < < < < < < < < ê Y C : Title 20—DEPARTMENT OF COMMERCE AND INSURANCE Division 2220—State Board of Pharmacy Chapter 7—Licensing 20 CSR 2220-7.010 General Licensing Rules PURPOSE: This rule defines terms used and general requirements governing board licensing activities as used in Chapter 7. (1) Definitions. (A) ACPE—Accreditation Council for Pharmacy Education. (B) Accredited school/college of pharmacy—a school or college of pharmacy accredited by ACPE and located in a U.S. state or territory. (C) Approved school/college of pharmacy—a Missouri school or college of pharmacy whose curriculum, physical equipment, course of instruction, and teaching personnel conform to ACPE standards and specifications and that has been recognized by the board as an approved school/college for pharmacy practice experience pursuant to 20 CSR 2220-7.027. (D) Board—the Missouri State Board of Pharmacy. (E) Foreign school/college—a school/college of pharmacy that is not located in the United States or a United States territory. (F) MPJE—Multistate Pharmacy Jurisprudence Examination. (G) NABP—National Association of Boards of Pharmacy. (H) NAPLEX—North American Pharmacist Licensure Examination. (2) An application shall not be considered filed if it has to be returned to the applicant for an incorrect or missing fee or an incomplete or missing signature or attestation/notarization. A pharmacist license application shall be deemed invalid if the applicant fails to submit or make available via NABP all information required to complete the application within ninety (90) days after the application is received by the board, with the exception of NAPLEX or MPJE examination scores. (3) No duplicate license, certificate, or registration shall be issued until the duplicate license fee has been paid and the most recent license, registration, or certificate has been returned to the board office or the licensee/registrant/certificate holder submits an attestation under penalty of perjury that the license, certificate, or registration has been lost, stolen, or destroyed. (4) Except as otherwise provided, all licensing and registration fees required by the rules of the board are nonrefundable. (5) A copy of proof of licensure/registration from the board’s official website may be used as proof of licensure by an applicant until a hard copy license/registration has been received from the board. (6) Failure to receive a renewal notice or application from the board shall not excuse the licensee/registrant from any renewal requirements established by Chapter 338, RSMo, or by rule of the board. AUTHORITY: sections 338.020, 338.030, 338.040, 338.043, 338.070, and 338.280, RSMo 2016, and section 338.140, RSMo Supp. 2025.* Original rule filed Jan. 10, 2013, effective Aug. 30, 2013. Amended: Filed May 31, 2022, effective Nov. 30, 2022. Amended: Filed Aug. 27, 2025, effective Feb. 28, 2026. *Original authority: 338.020, RSMo 1939, amended 1947, 1949, 1981, 1990, 2014; 338.030, RSMo 1939, amended 1949, 1951, 1981, 1990, 2001; 338.040, RSMo 1939, amended 1961, 1969, 1981, 1990; 338.043, RSMo 1990, amended 1997, 2001; 338.070, RSMo 1939, amended 1947, 1953, 1961, 1969, 1981, 1985, 1997; 338.140, RSMo 1939, amended 1981, 1989, 1997, 2011, 2019; and 338.280, RSMo 1951, amended 1971, 1981. 20 CSR 2220-7.025 Intern Pharmacist Licensure PURPOSE: This rule establishes requirements for intern pharmacist licensure and pharmacy practice experience. (1) The provisions of this rule shall be applicable to individuals seeking to earn pharmacy practice experience in Missouri. (2) Requirements for Licensure. Every person who desires to gain pharmacy practice experience in Missouri shall first apply for an intern pharmacist license. Application for licensure shall be made on forms provided by the board and shall be accompanied by the application fee. To be eligible for licensure, the applicant shall submit proof of fingerprinting as required by 20 CSR 2220-7.090 and must be— (A) Currently enrolled in a school or college of pharmacy that is located in a U.S. state or territory and is accredited by the Accreditation Council for Pharmacy Education (ACPE); (B) A graduate of an ACPE-accredited school or college of pharmacy who is actively seeking to earn pharmacy practice experience to qualify for Missouri pharmacist licensure; (C) A graduate of a foreign school/college of pharmacy as defined by 20 CSR 2220-7.040 with a completed pharmacist application on file with the board who has obtained Foreign Pharmacy Graduate Examination Committee (FPGEC) certification from the National Association of Boards of Pharmacy and is actively seeking to earn pharmacy practice experience to qualify for Missouri licensure; (D) Graduates of an ACPE-accredited pharmacy school/college with a completed and active pharmacist application on file with the board, provided the applicant holds a current and active pharmacist license from another U.S. state or territory; or (E) A graduate of an ACPE pharmacy school/college who is enrolled in a residency training program to be completed in Missouri that is accredited by the American Society of Health-System Pharmacists, or with a valid application for accreditation pending with the American Society of Health-System Pharmacists, or that is a residency program operated by or in conjunction with an ACPE-accredited school or college of pharmacy. (3) Site/Preceptor Approval. After licensure, an intern pharmacist shall only be authorized to earn pharmacy practice experience in a site approved by the board and under the supervision of a board approved preceptor. Requests for site and preceptor approval shall be submitted on a form provided by the board. The board may request additional information, interview program participants, or complete site inspections before a decision on an application is made. The intern pharmacist will receive confirmation from the board office noting approval of the site and preceptor and a start date after which pharmacy practice experience may be counted. In no event shall an intern pharmacist be credited for hours earned prior to being licensed by the board as an intern pharmacist. (A) Site Approval. The board shall only approve a site for pharmacy practice experience if the site holds a pharmacy license from a United States (U.S.) state or territory and such license is not under disciplinary action with the licensing entity. (B) Special Sites. An individual or entity/facility may petition the board to approve an entity/facility that is not a licensed pharmacy for purposes of intern training as a special site if the pharmacy practice experience to be earned complies with 20 CSR 2220-7.030(1)(A)3. Requests shall be made on a form provided by the board and shall include a detailed description of the pharmacy practice experience to be earned. The board may limit the number of pharmacy practice hours that may be earned at an approved special site. (C) Preceptor Approval. To be eligible for approval, a supervising preceptor shall hold a pharmacist license from a U.S. state or territory and such license must be active and not under disciplinary action in such U.S. state or territory. An individual/entity may petition the board to approve a preceptor that is not licensed as a pharmacist in a U.S. state or territory on a form provided by the board. The board may, in its discretion, approve a non-pharmacist preceptor if the preceptor is sufficiently qualified to train interns in the proposed pharmacy practice experience area(s) and the experience to be earned complies with the provisions of 20 CSR 2220-7.030(1)(A)3. The board may limit the amount of pharmacy practice hours that can be earned with a non-pharmacist preceptor. (D) Students enrolled in an approved school/college of pharmacy shall be authorized to earn experience as part of their school/college curriculum at any site or with any preceptor approved by the board or the school/college as authorized by 20 CSR 2220-7.027. However, students desiring to earn pharmacy practice experience outside of, or in addition to, the training/experience required as part of the curriculum of an approved school/college of pharmacy (i.e., non-school related summer employment) shall comply with the provisions of this rule for the additional hours earned and shall separately request prior approval by the board of the site/preceptor to be used. (4) Calculation of Hours. An intern pharmacist shall only be given credit for hours earned in activities related to the practice of pharmacy as determined by the board or connected with pharmaceutical or patient-centered care through the interpretation and evaluation of prescription orders; the compounding, dispensing, and labeling of drugs and devices pursuant to prescription orders; the proper and safe storage of drugs and devices and the maintenance of proper records of them; or consultation with patients and other health care practitioners about the safe and effective use of drugs and devices. (A) Except as otherwise provided herein, an intern pharmacist shall only receive credit for pharmacy practice experience that is earned after the date of licensure as an intern, at an approved site and under the supervision of an approved preceptor. (B) Certification of Hours. An intern pharmacist shall file a Preceptor’s Affidavit of Internship Hours at the completion of his/her pharmacy practice experience on a form provided by the board. The report shall identify the pharmacy practice experience hours earned at each approved training site and shall be signed by the supervising preceptor. No credit shall be granted for hours not reported to the board. In lieu of the preceptor affidavit, an approved school/college of pharmacy shall certify to the board the pharmacy practice experience earned by each student as part of the required curriculum. (C) The board may restrict the number of hours an intern pharmacist may earn per week. An intern pharmacist shall not be credited for hours earned while practicing/working as a pharmacy technician. (D) The board shall not certify or verify any pharmacy practice experience gained in Missouri unless the pharmacy practice experience complies with the requirements of this rule. Additionally, the board will not verify or certify hours earned by a student if the board does not receive certification from the preceptor or the school/college documenting the hours required by this rule. (5) Change of Intern Location/Preceptor. Except as provided for students of an approved school/college of pharmacy, an intern pharmacist shall promptly notify the board of a change in intern site/preceptor and shall request approval of the site/preceptor to be used. If approved, the intern pharmacist shall not be credited for hours earned more than ten (10) days prior to the date the approval request is filed with the board. No credit shall be granted for hours earned if the request for site/preceptor approval is subsequently disapproved by the board. (6) Intern pharmacists shall file an application to renew their intern pharmacist license between October 1 and December 31 of each even-numbered year. Applications shall be made on a form provided by the board and accompanied by the renewal fee. An intern pharmacist license shall not be renewed more than two (2) years after the intern pharmacist’s graduation from an ACPE-accredited school/college of pharmacy. For graduates of a foreign school/college of pharmacy who have obtained FPGEC certification from the National Association of Boards of Pharmacy, an intern pharmacist license shall not be renewed more than once. The board may approve additional renewals in the event of extraordinary circumstances due to no fault of the intern. An intern pharmacist license shall automatically terminate once the intern is issued a Missouri pharmacist license. AUTHORITY: sections 338.060 and 338.070, RSMo 2016, and sections 338.035 and 338.140, RSMo Supp. 2025.* Original rule filed Jan. 10, 2013, effective Aug. 30, 2013. Amended: Filed Dec. 27, 2019, effective July 30, 2020. ** Amended: Filed Dec. 28, 2020, effective June 30, 2021. Amended: Filed Aug. 27, 2025, effective Feb. 28, 2026. *Original authority: 338.035, RSMo 1990, amended 1993, 1995, 2007, 2020; 338.060, RSMo 1939, amended 1943, 1947, 1949, 1951, 1981, 1984, 1997, 1999; 338.070, RSMo 1939, amended 1947, 1953, 1961, 1969, 1981, 1985, 1997; and 338.140, RSMo 1939, amended 1981, 1989, 1997, 2011, 2019. **Pursuant to Executive Order 21-09, 20 CSR 2220-7.025, subsection (4)(C) was suspended from July 13, 2020 through September 15, 2021. 20 CSR 2220-7.027 Approved Missouri Schools/Colleges of Pharmacy PURPOSE: This rule establishes requirements for approval of pharmacy practice experience earned as part of the curriculum of a Missouri school/college of pharmacy. (1) Upon request, the board may approve a Missouri school/college of pharmacy for purposes of providing pharmacy practice experience to enrolled students. To be eligible for approval, the school/college of pharmacy must be located in Missouri and must— (A) Be accredited by the Accreditation Council for Pharmacy Education (ACPE) and comply with all applicable ACPE standards; (B) Require as part of the school/college curriculum or training, a minimum of one thousand five hundred (1,500) hours of pharmacy practice experience in activities related to the practice of pharmacy as determined by the board or connected with pharmaceutical or patient-centered care through the interpretation and evaluation of prescription orders; the compounding, dispensing, and labeling of drugs and devices pursuant to prescription orders; the proper and safe storage of drugs and devices and the maintenance of proper records of them; the administration of immunizations; or consultation with patients and other health care practitioners about the safe and effective use of drugs and devices; (C) Submit a list of all preceptors and sites that were used by the school/college curriculum for pharmacy practice experience within the previous year. The list must be submitted to the board annually for review, unless otherwise requested by the board; and (D) Submit the school’s/college’s policies and procedures for obtaining practice experience for board approval. The policies and procedures shall include policies/procedures for student training, approving sites/preceptors, and monitoring practice experience activities. (2) The board may, in its discretion, disapprove a Missouri school/college of pharmacy if the policies or procedures do not comply with the pharmacy practice experience requirements of this rule or Chapter 338, RSMo. Policies and procedures shall be resubmitted annually to the board for approval or as otherwise requested by the board. (3) A licensed intern pharmacist shall be authorized to earn pharmacy practice experience required by an approved school’s/college’s curriculum or training requirement at any site approved by the school/college for pharmacy practice experience, provided the site/preceptor complies with ACPE standards and meets the requirements of 20 CSR 2220-7.025(3) and (4). The board expressly reserves the right to disapprove a site/preceptor that does not comply with Chapter 338, RSMo, the rules of the board, or ACPE standards if deemed necessary to ensure proper intern training. (4) Certification of Hours. An approved school/college shall certify the pharmacy practice experience earned by a student to the board upon the student’s graduation or within thirty (30) days after the student is no longer enrolled in the pharmacy program. The board will not verify or certify hours earned by a student as part of the curriculum of a approved school/college if the board does not receive certification from the school/college documenting the hours earned. An intern pharmacist shall not be granted credit for hours earned while practicing/working as a pharmacy technician. AUTHORITY: sections 338.020 and 338.030, RSMo 2016, and section 338.140, RSMo Supp. 2025.* Original rule filed Jan. 10, 2013, effective Aug. 30, 2013. Amended: Filed Dec. 27, 2019, effective July 30, 2020. Amended: Filed Aug. 27, 2025, effective Feb. 28, 2026. *Original authority: 338.020, RSMo 1939, amended 1947, 1949, 1981, 1990, 2014; 338.030, RSMo 1939, amended 1949, 1951, 1981, 1990, 2001; and 338.140, RSMo 1939, amended 1981, 1989, 1997, 2011, 2019. 20 CSR 2220-7.030 Pharmacist Licensure by Examination PURPOSE: This rule establishes licensure requirements for examination applicants that have graduated from an accredited college/school of pharmacy. (1) Examination Applications. (A) Graduates of an Accreditation Council for Pharmacy Education (ACPE) accredited school/college of pharmacy may apply to the board for licensure as a Missouri pharmacist by examination. Applications shall be submitted on forms provided by the board with the examination application fee. The application must be notarized and include— 1. Satisfactory evidence that the applicant has graduated from an ACPE-accredited school/college of pharmacy that meets the requirements of this rule; 2. Proof that the applicant has completed a state and federal criminal history background check, as required by 20 CSR 2220-7.090; and 3. Proof of one thousand five hundred (1,500) hours of pharmacy practice experience in activities related to the practice of pharmacy as approved by the board or connected with— A. Patient-centered pharmaceutical care or pharmacist clinical services; B. Evaluating or interpreting prescriptions or medication orders; C. Compounding, dispensing, and labeling of drugs and devices; D. The proper and safe storage of drugs and devices and appropriate recordkeeping for them; E. Medication administration; F. Medication therapy review/management; and G. Consulting with patients and other health care practitioners about the safe and effective use of drugs and devices. (B) Pharmacy practice experience earned in another state must be certified directly to the board from an ACPE-accredited school/college of pharmacy or the state or governmental pharmacist licensing entity where the hours were earned. Alternatively, the board may, in its discretion, accept proof of graduation and the required pharmacy practice experience hours from National Association of Boards of Pharmacy (NABP). Graduates of an ACPE-accredited school/college of pharmacy located in a U.S. state or territory shall be deemed compliant with the pharmacy practice experience hours required by this rule and are not required to submit additional proof of pharmacy practice experience, unless otherwise requested by the board or the board’s authorized designee. (C) The board shall review the application and determine the candidate’s eligibility to test. Applications shall be deemed incomplete until all requirements of this rule have been met. All application fees are non-refundable. (2) Test Scheduling. When an application has been completed, the board will notify the applicant and/or NABP if he/she is eligible for the North American Pharmacist Licensure Examination (NAPLEX) and/or the Multistate Pharmacy Jurisprudence Examination (MPJE). If eligible, the applicant shall schedule testing dates for both the NAPLEX and MPJE, as required by NABP. The applicant must comply with all registration, application, testing, and scheduling requirements established by NABP for the examinations, and payment of any fee(s) required by NABP for scheduling/taking the examination(s). (A) To avoid forfeiture of eligibility, the applicant must take the examination(s) within three hundred sixty-five (365) days after having been determined eligible by the board to test. If the applicant does not take the examination within three hundred sixty-five (365) days, the applicant must reapply to the board for examination/licensure and pay the examination application fee again. (B) A determination by the board that an applicant is eligible for examination does not guarantee that the applicant will be issued a Missouri pharmacist license. The board reserves the right to deny an applicant for licensure that has been approved for examination as authorized by Missouri law. (3) Testing. Applicants for pharmacist licensure by examination must successfully pass both the NAPLEX and the MPJE. To successfully pass, a minimum score of seventy-five (75) is required for each of the required examinations. Applicants must pass both the NAPLEX and MPJE exams within two (2) years of submitting their application for licensure by examination to the board. Failure to achieve passing scores on both exams in this two (2) year period will result in the license application being rejected as incomplete. The applicant may reapply for licensure and restart the examination process, except as otherwise provided by subsection (4)(A) or other provisions of Missouri law. (4) Retesting. If an applicant fails to achieve a score of seventy-five (75) on both the NAPLEX and the MPJE, the candidate shall retake and pass the failed examination(s) before a license can be issued. Applicants seeking to retake an examination must file an application for re-examination with the board and pay the examination application fee each time. All examinations are scored independently and may be retaken independently. (A) The board or its authorized designee shall review and approve any applicant that fails the NAPLEX or MPJE three (3) consecutive times prior to the applicant being declared eligible to retest. A candidate will not be declared eligible to retest under this subsection until approved by the board. In lieu of disapproval, the board may establish a date after which the candidate shall be eligible to retest or may establish additional training or study requirements that must be completed before authorization to retest is granted. Applicants who fail the NAPLEX five (5) times shall not be declared eligible to retake the NAPLEX. Applicants who fail the MPJE five (5) times shall not be declared eligible to retake the MPJE unless otherwise approved by the board for extenuating circumstances. (B) Application for re-examination must be made on a form provided by the board. Examination/re-examination fees are non-refundable. (5) A pharmacist application shall be deemed invalid if the applicant fails to submit all information required to complete the application within six (6) months after the application is received by the board, with the exception of successful completion of the NAPLEX and/or MPJE. However, the application may remain active if the applicant has applied for licensure as a Missouri intern pharmacist to complete the required pharmacy practice experience and has completed all other application requirements, provided the application shall be deemed void if the applicant fails to complete the required pharmacy practice experience within two (2) years from the date the applicant’s pharmacist application was initially received by the board. AUTHORITY: sections 338.020, 338.040, 338.060, and 338.070, RSMo 2016, and sections 338.035 and 338.140, RSMo Supp. 2025.* Original rule filed Jan. 10, 2013, effective Aug. 30, 2013. Amended: Filed May 31, 2022, effective Nov. 30, 2022. Amended: Filed Aug. 27, 2025, effective Feb. 28, 2026. *Original authority: 338.020, RSMo 1939, amended 1947, 1949, 1981, 1990, 2014; 338.035, RSMo 1990, amended 1993, 1995, 2007, 2020; 338.040, RSMo 1939, amended 1961, 1969, 1981, 1990; 338.060, RSMo 1939, amended 1943, 1947, 1949, 1951, 1981, 1984, 1997, 1999; 338.070, RSMo 1939, amended 1947, 1953, 1961, 1969, 1981, 1985, 1997; and 338.140, RSMo 1939, amended 1981, 1989, 1997, 2011, 2019. 20 CSR 2220-7.040 Foreign Graduates PURPOSE: This rule establishes licensure requirements for pharmacist applicants who are graduates from a pharmacy school/college not located in the United States or a United States territory. (1) Definitions. (A) Foreign school/college—For purposes of this rule, a foreign school/college shall be defined as a school/college of pharmacy that is not located in a United States (U.S.) state/territory. (2) Applicability. The provisions of this rule are applicable to all graduates of a foreign school/college, including, graduates currently or previously licensed as a pharmacist by another U.S. state/territory. Graduates from a foreign school/college of pharmacy shall comply with the provisions of this rule prior to filing an examination application, an application for pharmacist licensure, or a reciprocity application. (3) Prior to applying for a Missouri pharmacist license, graduates of a foreign school/college shall first obtain Foreign Pharmacy Graduate Examination Committee Certification (FPGEC) from the National Association of Boards of Pharmacy (NABP). Potential applicants shall pay all fees and comply with all application/certification procedures required by NABP. (4) After receiving FPGEC certification, applicants shall file a Foreign Graduate Pharmacist License Examination Application with the board or, if applicable, a Foreign Graduate Pharmacist Transfer/Reciprocity Application, as provided in section (5). Applications shall be submitted on a form provided by the board and accompanied by the application fee and must include— (A) A copy of a certificate showing proof of name, date of birth, and place of birth by one (1) of the following methods: 1. Birth certificate; 2. Baptismal certificate; or 3. Notarized statement from an authorized governmental agency; (B) Documentation of name change, if the name on the credentials supplied for evaluation purposes is different than the name appearing on the application; (C) Proof of fingerprinting as required by 20 CSR 2220-7.090; (D) A copy of the applicant’s valid FPGEC certificate; (E) Proof of U.S. citizenship or, if the applicant is not a U.S. citizen, a copy of current visa, along with a copy of a U.S. employment authorization document such as an Alien Registration Receipt Card, Form I-551 or Employment Authorization Card Form I-688-B, or any other document approved or issued by the U.S. government permitting employment in the U.S.; and (F) Documentation as required by the board showing proof of one thousand five hundred (1,500) hours of pharmacy practice experience related to the practice of pharmacy that complies with 20 CSR 2220-7.030(1)(A)3. or proof that the applicant has maintained an active pharmacist license in another U.S. state/territory for a period of not less than one (1) year. To be eligible for licensure, the one thousand five hundred (1,500) hours of pharmacy practice experience must have been earned in a U.S. state/territory after the date the applicant obtained FPGEC certification. Applicants who have not yet completed the one thousand five hundred- (1,500-) hour experience requirement shall apply for licensure as an intern pharmacist and shall complete the required one thousand five hundred (1,500) hours before the application is approved. (5) Reciprocity/License Transfer. In addition to the requirements of this rule, graduates of a foreign school/college with a valid FPGEC certification who are currently licensed as a pharmacist in another U.S. state/territory shall also be governed by and comply with 20 CSR 2220-7.050 governing license transfer/reciprocity. (6) Test Scheduling for Foreign Graduates Applying for Licensure by Examination. When an application has been completed, the board will notify an applicant if he/she is eligible for the North American Pharmacist Licensure Examination (NAPLEX) and/or Multistate Pharmacy Jurisprudence Examination (MPJE) examinations. The applicant shall schedule test dates for both the NAPLEX and MPJE with NABP. The applicant shall satisfy all testing and scheduling requirements established by NABP and shall complete any necessary application(s) and payment of fee(s) for scheduling/taking the examination(s). (A) To avoid forfeiture of eligibility, the applicant must take the required examination(s) within three hundred sixty-five (365) days after having been determined eligible for examination by the board. If the applicant does not take the examination within three hundred sixty-five (365) days, the applicant must reapply to the board for examination/licensure and again pay the examination application fee. (B) A determination by the board that an applicant is eligible for examination does not guarantee that the applicant will be issued a Missouri pharmacist license. The board reserves the right to deny an applicant for licensure that has been approved to take the required examinations as authorized by Missouri law. (7) Testing. Applicants for licensure by examination shall successfully pass both the NAPLEX and the MPJE examinations. Applicants for licensure by transfer/reciprocity must successfully pass the MPJE. A minimum score of seventy-five (75) is required for each of the required examinations. Upon approval by the board and successful completion of the NAPLEX and MPJE, the board may issue a pharmacist license to the applicant. Applicants must pass the required examination(s) under this section within two (2) years of submitting their licensure application to the board. Failure to achieve passing score(s) within two (2) years will result in the license application being rejected as incomplete. The applicant may reapply for licensure and restart the examination process, except as otherwise provided by section (8) or other provisions of Missouri law. (8) Retesting. If an applicant fails to achieve a score of seventy-five (75) on both the NAPLEX and MPJE, the candidate shall retake and pass the failed examination(s) before a license can be issued. Any applicant who fails to achieve a passing score on either of the examinations shall file an application for reexamination with the board and pay the examination application fee each time. All examinations are scored independently and may be retaken independently. (A) The board shall review and approve any applicant that fails the NAPLEX or MPJE two (2) consecutive times prior to the applicant being declared eligible to retest. A candidate shall not be declared eligible to retest under this subsection until approved by the board. In lieu of disapproval, the board may establish a date after which the candidate shall be eligible to retest or may establish additional training or study requirements to be completed before authorization to retest is granted. Applicants who fail the NAPLEX five (5) times shall not be declared eligible to retake the NAPLEX. Applicants who fail the MPJE five (5) times shall not be declared eligible to retake the MPJE unless otherwise approved by the board for extenuating circumstances. (B) Application for reexamination shall be made on a form provided by the board. Fees for reexamination shall be non-refundable. (9) Upon approval by the board and successful completion of the NAPLEX and MPJE, the board shall issue a pharmacist license to the applicant. (10) A pharmacist license application pursuant to this rule shall be deemed invalid if the applicant fails to submit all information required to complete the application within six (6) months after the application is received by the board, with the exception of successful completions of the NAPLEX and/or MPJE. However, the application may remain active if the applicant has applied for licensure as a Missouri intern pharmacist to complete the required pharmacy practice experience and has completed all other preliminary application requirements, provided the application shall be deemed void if the applicant fails to complete the required pharmacy practice experience within two (2) years from the date the applicant’s pharmacist application was initially received by the board. AUTHORITY: sections 338.020, 338.040, 338.060, and 338.070, RSMo 2016, and sections 338.035 and 338.140, RSMo Supp. 2025.* Original rule filed Jan. 10, 2013, effective Aug. 30, 2013. Amended: Filed Aug. 27, 2025, effective Feb. 28, 2026. *Original authority: 338.020, RSMo 1939, amended 1947, 1949, 1981, 1990, 2014; 338.035, RSMo 1990, amended 1993, 1995, 2007, 2020; 338.040, RSMo 1939, amended 1961, 1969, 1981, 1990; 338.060, RSMo 1939, amended 1943, 1947, 1949, 1951, 1981, 1984, 1997, 1999; 338.070, RSMo 1939, amended 1947, 1953, 1961, 1969, 1981, 1985, 1997; and 338.140, RSMo 1939, amended 1981, 1989, 1997, 2011, 2019. 20 CSR 2220-7.050 License Transfer/Reciprocity PURPOSE: This rule establishes requirements for applicants for pharmacist licensure by license transfer/reciprocity. (1) The provisions of this rule shall be applicable to applicants for pharmacist licensure that are currently registered or licensed as a pharmacist in another United States (U.S.) state/territory who desire to be licensed by reciprocity or license transfer. (2) Foreign Graduates. Graduates of a school/college of pharmacy not located in a U.S. state/territory shall first comply with 20 CSR 2220-7.040. (3) Individuals seeking licensure by license transfer/reciprocity must file an electronic license transfer application with the National Association of Boards of Pharmacy (NABP). Potential applicants shall pay all NABP required fees and comply with all applicable NABP requirements. NABP will electronically forward the NABP electronic license transfer application to the board. The board will not accept NABP license transfer applications submitted directly by the candidate. (A) In addition to the NABP official license transfer application, applicants must file a Pharmacist License Transfer/Reciprocity Application with the board with the required application fee. The official application shall be attested to/notarized as requested by the board and shall be accompanied by proof of fingerprinting as required by 20 CSR 2220-7.090. (B) The Pharmacist License Transfer/Reciprocity application must be submitted to the board no more than three (3) months from the application completed date designated by NABP for the NABP electronic license transfer application. If the Missouri Pharmacist License Transfer/Reciprocity application is not submitted to the board within the required three (3) months, the applicant will be required to re-apply to NABP for an updated license transfer evaluation. Applicants shall complete all reevaluation/extension requirements and pay all applicable fees required by NABP. (4) Applicants for license transfer/reciprocity must pass the Multistate Pharmacy Jurisprudence Examination (MPJE) for Missouri with a minimum score of seventy-five (75). The board will notify NABP if the applicant is eligible to take the MPJE after the NABP application is filed. To be eligible for examination, the applicant shall— (A) Be currently registered or licensed as a pharmacist in another U.S. state/territory; (B) Have been licensed as a pharmacist by examination in another U.S. state/territory; (C) Have completed one thousand five hundred (1,500) hours of pharmacy practice experience related to the practice of pharmacy as determined by the board or shall have maintained an active pharmacist license for a period of not less than one (1) year in the state from which they are transferring that is not under disciplinary action; (D) Submit proof the applicant has completed a state and federal criminal history background check, as required by 20 CSR 2220-7.090; and (E) Submit a copy of the applicant’s Foreign Pharmacy Graduate Examination Committee Certification (FPGEC) certificate if the applicant is a graduate of a school/college of pharmacy not located in the United States. (5) Test Scheduling. When an application has been completed, the board shall notify the applicant if he/she is eligible for the MPJE examination. The applicant shall schedule a testing date for the MPJE with NABP. The applicant shall satisfy all testing and scheduling requirements established by NABP and complete any necessary application(s) and payment of fee(s) for scheduling/taking the examination. (A) To avoid forfeiture of eligibility, the applicant must take the examination within six (6) months after having been determined eligible by the board to test. If the applicant does not take the examination within six (6) months, the applicant must reapply to the board for examination/licensure and again pay the reciprocity application fee. Applicants who fail the MPJE five (5) times shall not be declared eligible to retake the MPJE unless otherwise approved by the board for extenuating circumstances. (B) A determination by the board that an applicant is eligible for examination does not guarantee that the applicant will be issued a Missouri pharmacist license. The board reserves the right to deny an applicant for licensure that has been approved to take the MPJE, as authorized by Missouri law. (6) Retesting. If an applicant fails to achieve a score of seventy-five (75) on the MPJE, the candidate shall retake and pass the examination before a license can be issued. Applicants who fail to achieve a passing score shall file an application for reexamination with the board and pay the examination application fee each time. All examinations are scored independently and may be retaken independently. (A) The board shall review and approve any applicant that fails the MPJE two (2) consecutive times prior to the applicant being declared eligible to retest. A candidate shall not be declared eligible to retest under this subsection until approved by the board. In lieu of disapproval, the board may establish a date after which the candidate shall be eligible to retest or may establish additional training or study requirements to be completed before authorization to retest is granted. (B) Applications for reexamination shall be submitted on a form provided by the board. Fees for reexamination shall be non-refundable. (7) Upon approval by the board and successful completion of the MPJE, the board may issue a pharmacist license to the applicant. All required fees must be paid prior to approval of a license transfer. Passing MPJE scores shall only be deemed valid for five (5) years, after which time the applicant must apply to retake the MPJE. AUTHORITY: sections 338.020, 338.040, 338.060, and 338.070, RSMo 2016, and sections 338.035 and 338.140, RSMo Supp. 2025.* Original rule filed Jan. 10, 2013, effective Aug. 30, 2013. Amended: Filed Aug. 27, 2025, effective Feb. 28, 2026. *Original authority: 338.020, RSMo 1939, amended 1947, 1949, 1981, 1990, 2014; 338.035, RSMo 1990, amended 1993, 1995, 2007, 2020; 338.040, RSMo 1939, amended 1961, 1969, 1981, 1990; 338.060, RSMo 1939, amended 1943, 1947, 1949, 1951, 1981, 1984, 1997, 1999; 338.070, RSMo 1939, amended 1947, 1953, 1961, 1969, 1981, 1985, 1997; and 338.140, RSMo 1939, amended 1981, 1989, 1997, 2011, 2019. 20 CSR 2220-7.060 Score Transfer PURPOSE: This rule defines requirements for transferring North American Pharmacist Licensure Examination scores to Missouri. (1) An applicant applying to take the North American Pharmacist Licensure Examination (NAPLEX) in another jurisdiction may have the score transferred to Missouri by requesting a score transfer from the National Association of Boards of Pharmacy (NABP). To be eligible for score transfer, the applicant must have achieved a minimum passing score of seventy-five (75) on the NAPLEX. The applicant shall complete all required score transfer forms/applications and pay any applicable fees as established by NABP. (2) A score transfer applicant shall apply for and shall be required to comply with all applicable licensing/application requirements as otherwise established by Chapter 338, RSMo, and 20 CSR 2220-7.010 through 20 CSR 2220-7.090. (3) A NAPLEX score transferred to Missouri shall only be deemed valid for a period of five (5) years. AUTHORITY: sections 338.020, 338.040, and 338.070, RSMo 2016, and section 338.140, RSMo Supp. 2025.* Original rule filed Jan. 10, 2013, effective Aug. 30, 2013. Amended: Filed Aug. 27, 2025, effective Feb. 28, 2026. *Original authority: 338.020, RSMo 1939, amended 1947, 1949, 1981, 1990, 2014; 338.040, RSMo 1939, amended 1961, 1969, 1981, 1990; 338.070, RSMo 1939, amended 1947, 1953, 1961, 1969, 1981, 1985, 1997; and 338.140, RSMo 1939, amended 1981, 1989, 1997, 2011, 2019. 20 CSR 2220-7.070 Temporary Pharmacist License (Post-Graduate Training) PURPOSE: This rule establishes requirements for obtaining a temporary pharmacist license to practice pharmacy for pharmacists completing post-graduate training programs. (1) Applicants for Post-Graduate Training. Pursuant to section 338.043, RSMo, a pharmacist licensed or registered in another state may apply for a temporary pharmacist license to complete a post-graduate pharmacy training program in the state of Missouri. (2) Applicants for a temporary pharmacist license shall file an application on a form provided by the board with the application fee. The application will not be considered unless it is fully completed and properly attested. The application shall include: (A) The name and signature of a Missouri-licensed pharmacist who will be supervising the applicant. The supervising pharmacist’s license shall be active in Missouri and shall not be under discipline with the board; (B) The name and address of all locations where the applicant will be practicing and a description of the applicant’s proposed duties; (C) A portrait photograph which measures two inches by two inches (2" × 2"); and (D) A protocol which outlines the applicant’s duties. At a minimum, the protocol shall define and include: 1. The type of practice to be performed and a specific job description of professional duties and functions to be completed; 2. The identity of the supervising pharmacist which includes a statement attesting to the ability and understanding of responsibilities involved; 3. A complete listing of all affiliations to be utilized during the licensure period; and 4. A complete listing of all locations where professional services will occur. (3) A Missouri-licensed pharmacist who agrees to supervise a temporary pharmacist licensee shall conduct general supervision during his/her tenure as supervisor. General supervision is defined as supervision required to ensure the temporary pharmacist licensee is practicing in compliance with Missouri law. In addition, the supervisor must be available for consultation with the licensee whenever necessary. The supervising pharmacist and the temporary pharmacist licensee shall timely submit reports to the board as may be required through protocol or as requested by the board in assessing outcomes or adherence to board requirements. (A) No applicant for a temporary pharmacist license shall commence practicing until the temporary pharmacist license is issued. (B) The board may terminate a temporary pharmacist license at its own discretion if, in the opinion of the board, any of the board requirements have not been adhered to. The licensee shall be notified in writing by mail when board action results in the termination of a temporary pharmacist license. (C) A temporary pharmacist licensee shall only be authorized to practice pharmacy at the location(s) identified in the temporary pharmacist’s application for licensure. A temporary pharmacist shall notify the board if the temporary licensee changes his/her supervising pharmacist. The board shall approve a change in supervising pharmacist prior to the supervision commencing. A temporary pharmacist licensee shall not practice under the supervision of a pharmacist without approval of the board. (D) A temporary pharmacist license issued pursuant to this rule automatically expires at the end of the applicant’s Missouri-based training program identified in the application and protocol. Temporary pharmacist licensees shall not practice pharmacy in this state beyond the expiration date of their temporary license. (4) The temporary licensing program is not intended to replace or conflict with any requirements or provisions of Missouri law or the rules of the board regarding internships or pharmacy practice experience. Students enrolled in a school/college of pharmacy seeking to rotate through a licensed pharmacy or to gain pharmacy practice experience in Missouri shall not qualify for licensure under this section but may apply for an intern license as governed by the rules of the board. (5) If a temporary pharmacist licensee desires to acquire a permanent license or desires to practice pharmacy outside the provisions of this rule, then the temporary licensee shall be required to complete all applicable Missouri pharmacist licensure requirements. If a permanent pharmacist application is denied by the board, the temporary pharmacist license shall be considered invalid after notification is sent to the applicant/licensee by certified mail. AUTHORITY: sections 338.020 and 338.070, RSMo 2000, and sections 338.043 and 338.140, RSMo Supp. 2012.* Original rule filed Jan. 10, 2013, effective Aug. 30, 2013. *Original authority: 338.020, RSMo 1939, amended 1947, 1949, 1981, 1990; 338.070, RSMo 1939, amended 1947, 1953, 1961, 1969, 1981, 1985, 1997; 338.043, RSMo 1990, amended 1997, 2001; and 338.140, RSMo 1939, amended 1981, 1989, 1997, 2011. 20 CSR 2220-7.075 Temporary Pharmacist License for Non-Resident Military Spouses PURPOSE: This rule establishes requirements for obtaining a temporary pharmacist license for non-resident military spouses as authorized by section 324.008, RSMo. (1) A non-resident spouse of an active duty member of the Armed Forces of the United States who has been transferred or is scheduled to be transferred to the state of Missouri, is domiciled in the state of Missouri, or who has moved to the state of Missouri on a permanent change-of-station basis, may apply for a temporary Missouri pharmacist license to practice in this state. To be eligible for a temporary pharmacist license under this rule, the nonresident military spouse must meet the requirements of section 324.008, RSMo. No application fee shall apply. (2) Applicants for a temporary pharmacist license must file an application on a form provided by the board that includes: (A) The applicant’s name and address; (B) The name and address of all locations where the applicant will be practicing, if known; (C) A portrait photograph which measures two inches by two inches (2" × 2"); (D) Official verification from a state or territory of the United States showing that the applicant holds a current and active pharmacist license in the applicable state or territory; (E) Evidence that the applicant meets the practice requirements of section 324.008.3, RSMo; and (F) An attestation that the temporary pharmacist agrees to comply with all state and federal laws applicable to the practice of pharmacy, including, but not limited to, Chapter 338, RSMo, the rules of the board and all controlled substance laws. (3) A temporary license under this section shall be valid for one-hundred eighty (180) days but may be extended for an additional one-hundred and eighty (180) days for good cause at the discretion of the board. Temporary pharmacist licensees cannot practice pharmacy in Missouri beyond the expiration date of their temporary license. (4) A temporary pharmacist must complete all applicable Missouri pharmacist licensure requirements to acquire a permanent Missouri pharmacist license. If a permanent pharmacist application is denied by the board, the temporary pharmacist license shall be considered invalid after notification is sent to the applicant/licensee by certified mail. AUTHORITY: sections 324.008 and 338.043, RSMo 2016, and section 338.140, RSMo Supp. 2019.* Original rule filed Nov. 6, 2019, effective May 30, 2020. *Original authority: 324.008, RSMo 2011; 338.043, RSMo 1990, amended 1997, 2001; and 338.140, RSMo 1939, amended 1981, 1989, 1997, 2011, 2019. 20 CSR 2220-7.080 Pharmacist License Renewal and Continuing Pharmacy Education PURPOSE: This rule establishes renewal and continuing education requirements for relicensure of pharmacists in Missouri. (1) All pharmacist licensees shall apply to renew their Missouri pharmacist license on or before October 31 of every even-numbered year. Applicants shall file a renewal application on a form provided by the board and pay the renewal fee. The renewal application must be completed correctly and in its entirety in order for it to be processed and the license renewed. Any portion of the application that is incomplete or inaccurate shall result in the rejection of the renewal application and require its return to the applicant for correction. (A) No active pharmacist license will be renewed by the board unless the applicant has fulfilled the continuing education requirements as set forth in section 338.060, RSMo, and the provisions of this rule. At the time of renewal, a licensee shall truthfully attest he/she has completed the continuing education requirements required by this rule. The attestation shall be submitted with the renewal application and shall truthfully affirm that the licensee has completed all continuing education requirements and that proof of continuing education completion has been maintained by the pharmacist as required by section (2) of this rule. The required continuing education must be completed by the date the renewal is signed or submitted to the board. (B) A Missouri pharmacist license that has not been renewed by the board on or before October 31 of each even-numbered year shall be deemed expired. Upon expiration, the holder of an expired license shall be deemed no longer licensed and shall not practice pharmacy in the state of Missouri until the license has been renewed by the board. To renew an expired license, the holder shall file a renewal application with the board and shall pay all delinquent fees. A delinquent fee shall not be required if the renewal application was postmarked or submitted via the board’s electronic renewal system on or before October 31 of each even-numbered year. Renewal applications received prior to October 31 that are returned to the applicant for correction will not be considered late and subject to the delinquent fee if the corrected application is returned to the board within thirty (30) days after receipt. (C) Any person who fails to renew his/her pharmacist license within two (2) years of its expiration shall be treated in the same manner as a person who has never been licensed and shall be required to file a new pharmacist license application with the board. (2) Required Hours. As a condition of renewal, all active Missouri pharmacist licensees shall complete thirty (30) hours of continuing education during the two (2) year continuing education reporting period preceding renewal of the license. For purposes of this rule, the reporting period is the twenty-four- (24-) month period beginning on November 1 of even-numbered years and ending on October 31 of even-numbered years. Continuing education hours earned after October 31 of even-numbered years shall apply to the next continuing education period. (A) A pharmacist first licensed by the board within twelve (12) months immediately preceding the October 31 biennial renewal date shall be exempt from the continuing pharmacy education requirements for that reporting period. (B) Hours obtained in excess of the thirty (30) hours required by this rule may not be carried forward to satisfy the requirements for the next reporting period. (3) Continuing Education Course Approval. (A) Except as otherwise provided herein, continuing education shall only be granted for a post-graduate course that is related to the practice of pharmacy and that is— 1. Approved by the Accreditation Council for Pharmaceutical Education (ACPE) for continuing education; 2. Offered by a state, federal, or local governmental or regulatory agency and approved by the board; or 3. Related to the practice of pharmacy, as approved by the board. (B) Continuing education courses may include institutes, seminars, lectures, conferences, workshops, extension study, correspondence courses, teaching, professional meetings, self-study courses, and any other methods approved by the board. The courses must be pharmacy related and shall comply with the other continuing education requirements of this rule. (C) Continuing pharmacy education programs approved by ACPE shall be accepted as approved continuing education courses for purposes of license renewal and are not required to be individually submitted to the board for prior approval. (D) The board shall not grant continuing education credit for any course that is taken before it is approved by the board or ACPE. (E) One (1) continuing education contact unit (CEU) will be the equivalent of ten (10) clock hours of participation in programs approved by the board. (4) Non-ACPE Approved Programs. Programs that are not ACPE approved must be approved by the board prior to being taken as a continuing education course. To be eligible for approval, a program shall provide for evaluation methods or examinations to assure satisfactory completion by participants. Addition-ally, the person(s) who is to instruct or who is responsible for the delivery or content of the program shall be qualified in the subject matter by education or experience. (A) Continuing education approval requests shall be submitted to the board on forms provided by the board. The applicant shall provide detailed information relating to administration and organization of the course, teaching staff, educational content and development, methods of delivery, facilities, and evaluation. (B) Continuing education program approval applications should be submitted at least thirty (30) days prior to the date of the proposed continuing education program, to ensure the program is approved for continuing education credit prior to the course being taken. Applications received less than thirty (30) days prior to the date of the program cannot be guaranteed to be approved prior to the date of the program. No application for approval of continuing education programs will be accepted if received less than ten (10) business days from the date such program is to be offered for continuing education purposes. (C) Applications returned due to errors or for purposes of requesting more information shall not be considered to be received by the board until the requested corrections and/or information are made and received by the board. (D) The executive director shall review applications for continuing education programs and may approve or deny such requests. Applicants shall be notified after a decision to approve or deny a program has been made. (5) Credit for Educational Training. (A) Any pharmacist who leads, instructs, or lectures to groups of nurses, physicians, pharmacists, or others on pharmacy-related topics in organized continuing education or in-service programs shall be granted continuing education credit for the time expended during actual presentation upon adequate documentation to the board. However, a pharmacist whose responsibility is the education of health professionals shall only be granted continuing education credit for time expended in leading, instructing, or lecturing to groups of physicians, pharmacists, nurses, or others on board-approved pharmacy-related topics in an organized continuing education or in-service program outside of his/her formal responsibilities. (B) Approval shall be requested using the procedures in section (4) of this rule. Credit for the same presentation or program will only be granted once during a renewal period. (6) Graduate Studies. Continuing education credit will be given for undergraduate or graduate studies taken as a post-graduate in any regionally accredited pharmacy, medical, or dental e d u c a t i o n a l i n s t i t u t i o n o f h i g h e r l e a r n i n g . T o b e e l i g i b l e f o r c r e d i t , t h e s t u d i e s m u s t b e r e l a t e d t o t h e p r a c t i c e o f p h a r m a c y . C r e d i t f o r u n d e r g r a d u a t e / g r a d u a t e s t u d i e s a u t h o r i z e d b y t h i s r u l e s h a l l b e a s s e s s e d a s f o l l o w s : ( A ) 3 h o u r s c o l l e g e c r e d i t = 15 CE hours (B) 2 hours college credit = 10 CE hours (C) 1 hour college credit = 5 CE hours (7) Licensees may obtain four (4) hours (0.4 CEU) of continuing education by attending a complete open session of a board meeting at which disciplinary hearings are scheduled, subject to the following: (A) The licensee must sign in with the executive director or designee of the board before the meeting day begins; (B) Licensees cannot receive continuing education credit for attendance at a board meeting if required to appear before the board; (C) The licensee must remain in continuous attendance during the open session meeting, provided attendance shall not be required for more than eight (8) hours of an open session meeting. Except as otherwise provided in this section, partial credit will not be given if the licensee is not in attendance for the entire open session meeting; (D) The maximum continuing education hours allowable for board meeting attendance pursuant to this subsection shall be limited to eight (8) credit hours (0.8 CEU) per biennial pharmacist renewal period. (8) No information or advertisements shall contain information that a continuing education program has been approved by the board unless the program is accredited by ACPE or notification has been received from the board that the program has been approved. (9) Inactive Licenses. In lieu of submitting proof of continuing education, a pharmacist may apply for an inactive license at the time of license renewal. To be deemed inactive, the pharmacist shall file a renewal application with the board with the applicable fee and request inactive status on the renewal application. An inactive license shall then be issued and may be renewed at subsequent renewal periods. While the inactive license is in effect, the pharmacist shall not practice pharmacy. (A) The renewal fee will be the same for active and inactive licenses. (B) Before an inactive license can be returned to active status, the licensee shall submit proper evidence that he/she has obtained at least fifteen (15) continuing education hours for each year that his/her license was inactive. The licensee may obtain the required continuing education hours during any time period while the license is on inactive status, as long as the hours are obtained prior to applying for return to active status. (10) Any licensee who has an expired pharmacist license and seeks to renew the license pursuant to section 338.060.2, RSMo, shall present proper evidence that he/she has obtained the required number of continuing education hours during the period that his/her license was expired. (11) A pharmacist shall maintain proof of completion of continuing education credits for a minimum of four (4) years after the continuing education has been completed. Licensees shall maintain a completed certification from ACPE or the approved continuing education provider indicating the course name and date of the program, the name of the participant, the date credit was earned, and, if applicable, the ACPE course number. (12) The board may audit a licensee to assess the authenticity and validity of continuing education hours submitted for relicensure. Failure to provide proof of completion of the required continuing education credits when requested to do so by the board shall be considered a violation. (A) In accordance with section 338.060, RSMo, any licensee that has not completed and retained the required evidence of all required continuing education shall complete any outstanding continuing education and pay a delinquent fee as provided by this rule and may be subject to disciplinary action pursuant to section 338.055, RSMo. The board may also audit past renewal periods and/or require that proof of continuing education credits be submitted with the licensee’s renewal application. (B) The following continuing education delinquent fees are applicable: 1. Less than one (1) hour missing one hundred dollars ($100); 2. Two (2) to ten (10) hours missing five hundred dollars ($ 500); 3. Eleven (11) to fifteen (15) hours missing seven hundred fifty dollars ($750); or 4. Sixteen (16) or more hours missing one thousand dollars ($1,000). AUTHORITY: sections 338.020, 338.060, and 338.070, RSMo 2016, and section 338.140, RSMo Supp. 2019.* Original rule filed Jan. 10, 2013, effective Aug. 30, 2013. Amended: Filed May 6, 2019, effective Nov. 30, 2019. ** *Original authority: 338.020, RSMo 1939, amended 1947, 1949, 1981, 1990, 2014; 338.060, RSMo 1939, amended 1943, 1947, 1949, 1951, 1981, 1984, 1997, 1999; 338.070, RSMo 1939, amended 1947, 1953, 1961, 1969, 1981, 1985, 1997; and 338.140, RSMo 1939, amended 1981, 1989, 1997, 2011, 2019. **Pursuant to Executive Order 21-07, 20 CSR 2220-7.080, section (2) was suspended from July 13, 2020 through August 5, 2021. 20 CSR 2220-7.090 Fingerprint Requirements PURPOSE: This rule establishes guidelines for the submission of fingerprints by applicants. (1) Applicants for licensure or registration required to provide fingerprints to the board shall include: (A) All pharmacist applicants, including, applicants by examination, score transfer, reciprocity/transfer, and foreign graduates; (B) Drug distributor license manager-in-charge (unless currently licensed as a pharmacist in the state of Missouri); (C) Pharmacy technician applicants; (D) Owners with a ten percent (10%) or more interest in a drug distributor applicant (non-publicly held companies only); and (E) Intern pharmacist applicants. (2) An applicant required to submit fingerprints pursuant to this rule shall submit fingerprints for the purpose of conducting a criminal background check by the Missouri State Highway Patrol (MSHP) and Federal Bureau of Investigation (FBI). The applicant shall provide proof of submission of fingerprints to MSHP’s approved vendor(s) for both a MSHP and FBI criminal history background check. Proof shall consist of any documentation acceptable to the board. Any fees due for a fingerprint background check shall be paid by the applicant directly to the MSHP or its approved vendor(s). (3) Information collected under this criminal history review will be held as confidential in accordance with state and federal laws governing the dissemination of criminal history information. (4) The board may require an applicant to be fingerprinted again and pay any required fingerprinting fees, if the application process is not completed within six (6) months of the board’s receipt of the application. (5) The board may, in the course of an investigation of a licensee, require that fingerprints be submitted for a criminal history background check as provided for in this rule. AUTHORITY: sections 338.020, 338.040, 338.070, and 338.280, RSMo 2000, and sections 338.035 and 338.140, RSMo Supp. 2012.* Original rule filed Jan. 10, 2013, effective Aug. 30, 2013. - . S T g h ’ “ ì T U Û Ü 5 6 e f ä å Q R  Ž v w ý þ y z â D E Œ 5 6 Æ Ç èèÒÒÒÒºº¢¢¢¢¢¢uu /hAXŠ h‰3&